Abstract
The apoA-I mimetic peptide L-4F [(Ac-D-W-F-K-A-F-Y-D-K-V-A-E-K-F-K-E-A-F-NH2) synthesized from all L-amino acids] has shown potential for the treatment of a variety of diseases. Here, we demonstrate that LDL promotes association between L-4F and HDL. A 2- to 3-fold greater association of L-4F with human HDL was observed in the presence of human LDL as compared with HDL by itself. This association further increased when LDL was supplemented with the oxidized lipid 15S-hydroxy-5Z, 8Z, 11Z, 13E-eicosatetraenoic acid (15HETE). Additionally, L-4F significantly (P = 0.02) promoted the transfer of 15HETE from LDL to HDL. The transfer of L-4F from LDL to HDL was demonstrated both in vitro and in C57BL/6J mice. L-4F, injected into C57BL/6J mice, associated rapidly with HDL and was then cleared quickly from the circulation. Similarly, L-4F loaded onto human HDL and injected into C57BL/6J mice was cleared quickly with T(1/2) = 23.6 min. This was accompanied by a decline in human apoA-I with little or no effect on the mouse apoA-I. Based on these results, we propose that i) LDL promotes the association of L-4F with HDL and ii) in the presence of L-4F, oxidized lipids in LDL are rapidly transferred to HDL allowing these oxidized lipids to be acted upon by HDL-associated enzymes and/or cleared from the circulation.
Highlights
The apoA-I mimetic peptide 4F synthesized from all L-amino acids (L-4F) [(Ac-D-W-F-KA-F-Y-D-K-V-A-E-K-F-K-E-A-F-NH2) synthesized from all Lamino acids] has shown potential for the treatment of a variety of diseases
When 14C-L-4F was incubated with fasted human plasma it associated almost completely with the HDL fraction as determined by fast protein liquid chromatography (FPLC) fractionation (Fig. 1A)
Similar results were obtained for the association of 14C-L-4F with C57BL/6J mouse plasma lipoproteins
Summary
The apoA-I mimetic peptide L-4F [(Ac-D-W-F-KA-F-Y-D-K-V-A-E-K-F-K-E-A-F-NH2) synthesized from all Lamino acids] has shown potential for the treatment of a variety of diseases. L-4F loaded onto human HDL and injected into C57BL/6J mice was cleared quickly with T1/2 = 23.6 min This was accompanied by a decline in human apoA-I with little or no effect on the mouse apoA-I. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. The mimetics differ with respect to the number of phenylalanines present on the nonpolar face of the amphipathic helix, ranging from the two phenylalanines of the original 18A (since named 2F) up to seven phenylalanines (so-called 7F) [6] Because of their common class A helical structure, all six mimetics in this group reproduce the basic lipidassociating properties of apoA-I [1, 6]. M.N., S.T.R., G.M.A. and A.M.F. are principals in Bruin Pharma and A.M.F. is an officer in Bruin Pharma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.